David Schiff

29PUBLICATIONS

139CO-AUTHORS

Molecular targetsBiological adaptationPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (29)

Sort by Publication Date:

|May 22, 2026

Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data.

|Apr 14, 2026

Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial.

Patrick Y Wen, Donald A Berry, Meredith B Buxton

|Dec 29, 2025

Presenting clinical and radiographic features of diffuse glioma molecular subtypes in accordance with the 2021 CNS5 WHO classification.

Jasmin Jo, Mark Willy L Mondia, Josephine Arewa

|Aug 21, 2025

Effects of re-challenge with temozolomide in grade 2/3 IDH mutant gliomas at first progression.

Lalanthica V Yogendran, Abhinav Kareddy, Salma O Abbas

|Aug 19, 2025

Glioblastoma in adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.

Patrick Y Wen, Michael Weller, Eudocia Q Lee

|Apr 30, 2025

Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline Rapid Recommendation Update.

Jaishri Blakeley, Nimish A Mohile, Hans Messersmith

Pageof 5

Frequent Collaborators

Andrew Lassman

Hans Messersmith

P P Batchala

Paul D Brown

Camilo E Fadul

Jaishri Blakeley

M-B Lopes

Ingo Mellinghoff

S H Patel

David A Reardon

Frequent Collaborators

Andrew Lassman

Hans Messersmith

P P Batchala

Paul D Brown